Hydroxybenzamide Derivatives for ER Stress-Protected β-Cell Survival
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing treatments for diabetes, particularly those targeting ER stress in pancreatic β cells, have a narrow range of potency and fail to effectively protect β cell function, leading to irreversible cell death and dysfunction.
Innovation Solution
Development of novel hydroxybenzamide derivatives, such as 3-hydroxy-N-(4-(trifluoromethyl)benzyl)benzamide (WO3i), which inhibit ER stress-induced activation of the UPR pathways, thereby preserving β-cell viability and function.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If existing treatments targeting ER stress in pancreatic β cells are used, then some β cell protection is achieved, but the range of potency is narrow and protection is insufficient
Solution Approach 1:
The patent applies parameter changes by systematically modifying the chemical structure of triazole derivatives, specifically adjusting substituents at positions R1, R2, R3, R4, R5, and R6 to optimize β cell protective activity. This includes varying hydrophobic, electron-withdrawing, and hydrogen-bonding groups to enhance potency across different ER stress conditions, thereby expanding the range of effectiveness while maintaining reliable protection.
Solution Approach 2:
The patent employs composite material principles by creating hybrid molecular structures that combine triazole core with diverse aromatic substituents (benzyl, phenyl, naphthyl groups) and functional moieties (hydroxyl, methoxy, halogen, trifluoromethyl groups). This composite approach generates compounds with enhanced and tunable potency ranges while maintaining effective β cell protection through synergistic structural features.
2Reliability
If existing triazole derivatives are used to protect β cells, then some protective effect is observed, but the compounds show narrow range of potency and fail to effectively protect β cell function
Solution Approach 1:
The patent systematically varies chemical parameters including substituent types (electron-withdrawing groups like CF3, NO2; hydroxyl groups; methoxy groups), positional isomers, and molecular weight to expand potency range. Specific modifications at R1-R6 positions enable tuning of compound activity across broad concentration ranges while maintaining reliable β cell viability preservation under various ER stress conditions.
Solution Approach 2:
The patent segments the molecular structure into distinct functional domains: the triazole core (provides basic protective activity), aromatic substituents (enhance potency and selectivity), and hydroxyl/methoxy groups (improve solubility and bioavailability). This segmentation allows independent optimization of each domain to achieve both broad potency range and reliable β cell protection.
Data Source
AI summary
Hydroxybenzamide derivative compounds having β-cell protective activity against ER stress, and methods of their use in treating diabetes and other conditions and diseases associated with ER stress. In one non-limiting embodiment, the derivative is 3-hydroxy-N-(4-(trifluoromethyl)benzyl)benzamide.